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Recurring activations of the prevalent latent herpes viruses Cytomegalovirus (CMV) and 
Epstein-Barr virus (EBV) induces immune cell division leading to the premature terminal 
differentiation of T-cells.  Terminally differentiated T-cells are known to accumulate with 
age causing a reduction in the naïve T-cell repertoire, which compromises the ability of 
the adaptive immune system to respond to novel pathogens. Although CMV and EBV 
seropositivity are hallmarks of the “immune risk profile” and are known to influence the 
frequency of terminally differentiated T-cells and increase infection risk in adults, it is not 
known if CMV or EBV impacts on the frequency of these cells in a young subject cohort.  
PURPOSE: To examine the impact of CMV and EBV seropositivity on the frequency of 
highly differentiated blood T-cells in Mexican-American adolescents. METHODS: 
Fasted resting blood samples were obtained from 77 adolescents consisting of both 
males and females. The presence of antibodies against CMV and EBV was determined 
in serum by ELISA. Lymphocytes isolated from peripheral blood were assessed for a 
combination of cell surface markers to determine their stage of differentiation. 
Monoclonal antibodies and four-color flow cytometry were used to identify senescent 
(CD27-, CD28-, CD57+), naïve (CCR7+, CD45RA+), memory (CCR7-, CD45RA-) and 
effector memory (CCD7-, CD45RA+) T-cell markers on pan CD3+ T-cells, CD4+ T-cells 
and CD8+ T-cells. Differences in T-cell phenotype between the CMV/EBV seropositive 
and seronegative participants were compared using independent Student t-tests. 
RESULTS: The prevalence of latent CMV and EBV infection among the subject cohort 
was 16% and 44% respectively, while 7% of all participants were carrying a latent 
infection for both. No differences in senescent and memory phenotypes were found 
between the CMV or EBV seropositive and seronegative groups. CONCLUSION: 
Despite the known influence of latent CMV and EBV infection on the frequency of 
senescent T-cells in adults, these preliminary data indicate that CMV and EBV 
seropositivity has no impact on the frequency of senescent T-cells in adolescents. 
These data suggest that the increased frequency of terminally differentiated T-cells that 
are associated with CMV and EBV seropositivity in adults is probably due to long-term 
infections. Future studies will assess the impact of CMV and EBV seropositivity on 
immunosenescence in association with other factors known to have an effect on T-cells 
differentiation, such as BMI and physical activity status. 
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